Improving care for babies born with opioid withdrawal
Part of Genetic & congenital, Mental health clinical trials.
This program helps participating hospitals improve care for newborns who may go through opioid withdrawal (also called neonatal abstinence syndrome). It mainly aims to make mother-baby support and treatment plans work better after delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born after 36 weeks of pregnancy
- Your baby’s mother used opioids during pregnancy (or is in a supervised treatment program for opioid use)
- You are being cared for at a hospital that is part of this program
- Your baby was not born very early and is not expected to be in the NICU for the reasons listed below
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve care for mothers with opioid use disorder and their babies with neonatal abstinence syndrome. Researchers will interview healthcare providers and mothers to develop better support programs.
This study looks at tiny genetic signals (microRNA) in newborn samples to identify neonatal opioid withdrawal syndrome. It may help doctors recognize withdrawal sooner, so babies can get the right care faster.
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
This study looks at different medicine approaches to treat newborns with opioid withdrawal (NOWS). It compares how well babies do with standard care and may help find the best way to manage symptoms and support recovery.
This study tests a team-based approach to help pregnant women with opioid use disorder get better support during pregnancy. It may improve care for mothers and babies.
This study helps pregnant people who struggle with opioid use and are starting or considering medication treatment. Researchers will track your health and your baby's health to learn how to best support you during and after pregnancy.
Hear when a new Neonatal Abstinence Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.